Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISE-D
NCT03993457Phase 4Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, bupropion in major depressive disorder (MDD), sponsored by UT Southwestern Medical Center. Started Jul 2019; status: terminated.
02
Drugs
escitaloprambupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03993457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03993457.